OKLAHOMA CITY, June 22, 2011 /PRNewswire/ -- Graymark Healthcare, Inc. (NASDAQ: GRMH), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), has appointed Steven Glen Hull, MD as Graymark's new chief medical officer, effective immediately.
Dr. Hull succeeds Kevin Lewis, MD, who departed Graymark to pursue other interests.
Dr. Hull brings to the position more than 15 years of sleep medicine experience, serving in a variety of upper-level management and director roles for numerous sleep centers and facilities.
Dr. Hull was promoted to CMO from his position as president and medical director of somniTech and somniCare, divisions of Graymark that operate several sleep centers and sleep apnea therapy sites in the Midwest.
He will maintain these positions as well as remain on staff in his part-time role as the director of sleep disorders and vaccine research for Vince and Associates Clinical Research, an independently owned research company.
He also previously served as CEO of Avastra Sleep Centers, as well as associate medical director and sleep disorders clinical director with Kaiser Permanente Medical Group of Mid-America.
accomplished career also includes serving on the Blue Cross Blue Shield of Kansas City Medical Advisory Committee
and as chairman of the Continuing Medical Education Committee for the American Academy of Sleep Medicine
He received his B.S. in Biology from the University of Illinois and earned his medical degree from Southern Illinois University, and was formerly a clinical assistant professor at the Department of Family Medicine, Kansas City University of Medicine and Biosciences.
He is an accomplished researcher as a principal or sub-investigator in more than 275 clinical trials primarily focused on sleep.
He is also a well-published author and former associate editor of the journal "Sleep" and "The Journal of Clinical Sleep Medicine."
"Steven brings to this important position a tremendous breadth of knowledge, experience and accomplishment in the sleep medicine field, as well as strong track record of effective leadership and sleep care at somniTech and somniCare," said Stanton Nelson, Graymark's chairman and CEO.
commented: "This appointment is an honor as well as an exciting opportunity to advance the success and market expansion of Graymark's
sleep care model. Working closely with our medical directors and staff, I will focus on improving the outcomes of those we serve through our comprehensive sleep diagnostic services, treatment, and follow up programs."